For research use only. Not for therapeutic Use.
LS-58500(Cat No.:I031049)is a small molecule being investigated for its potential therapeutic applications in cancer treatment. It is known to inhibit key signaling pathways involved in tumor growth and survival. LS-58500 targets specific enzymes and receptors that regulate cell division and proliferation, thereby preventing cancer cells from multiplying and spreading. Research on LS-58500 has focused on its ability to enhance the effects of other cancer treatments, including chemotherapy and targeted therapies. Although it is still in the preclinical or early clinical stages, LS-58500 holds promise as part of novel cancer treatment strategies.
Catalog Number | I031049 |
CAS Number | 39071-30-2 |
Synonyms | LS-58500; LS 58500; LS58500; |
Molecular Formula | C27H36O8 |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | [(1R,2S,6R,10S,11R,12S,13S,15R)-12-(acetyloxymethyl)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,15-trimethyl-5-oxo-13-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] (E)-2-methylbut-2-enoate |
InChI | InChI=1S/C27H36O8/c1-7-14(2)23(31)35-26-10-16(4)27(33)19(21(26)24(26,6)13-34-17(5)29)9-18(12-28)11-25(32)20(27)8-15(3)22(25)30/h7-9,16,19-21,28,32-33H,10-13H2,1-6H3/b14-7+/t16-,19+,20-,21-,24-,25-,26+,27-/m1/s1 |
InChIKey | PGLQDKDOYFHAMW-GFCXBYCNSA-N |
SMILES | C/C=C(\C)/C(=O)O[C@@]12C[C@H]([C@]3([C@H]([C@@H]1[C@@]2(C)COC(=O)C)C=C(C[C@]4([C@H]3C=C(C4=O)C)O)CO)O)C |